학술논문
A phase I and pharmocokinetic study of exatecan mesylate administered as a protracted 21-day infusion in patients with advanced solid malignancies
Document Type
Article
Author
Source
In: Clinical Cancer Research . (Clinical Cancer Research, 1 July 2003, 9(7):2527-2537)
Subject
Language
English
ISSN
10780432